Review Fabry disease: a review of current management strategies

A. MEHTA, M. BECK, F. EYSKENS, C. FELICIANI, I. KANTOLA, U. RAMASWAMI, A. ROLFS, A. RIVERA, S. WALDEK and D.P. GERMAIN From the Lysosomal Storage Disorders Unit, Department of Haematology, Royal Free Hospital and University College London School of Medicine, London, UK, Children’s Hospital, University of Mainz, Mainz, Germany, Department of Metabolic Diseases, ZNA Middelheim General Hospital, Antwerp, Belgium, Department of Dermatology, Università Cattolica del Sacro Cuore, Rome, Italy, Department of Medicine, Turku University Hospital, Turku, Finland, Paediatric Metabolic Unit, Addenbrooke’s Hospital, Cambridge, UK, Albrecht-Kossel-Institute for Neuroregeneration, Medical Faculty, University of Rostock, Rostock, Germany, Department of Internal Medicine, Complejo Hospitalario, Universitario de Vigo, Hospital Xeral de Vigo, Vigo, Spain, Department of Adult Metabolic Diseases, Salford Royal NHS Foundation Trust, Salford, UK and Division of Medical Genetics, Hôpital Raymond Poincaré (AP-HP), University of Versailles, St. Quentin en Yvelines, 92380 Garches, France